Surgical versus optical treatment for anisometropia in adults: A randomized controlled trial by Iqbal, Mohammed et al.
 
 
Med Hypothesis Discov Innov Optom. 2020; 1(2)  
 





Surgical versus optical treatment for anisometropia in 
adults: a randomized controlled trial 
Mohammed Iqbal 1 , Ali Mahmoud 1, Marcos Zarif 2, Ahmad Gad 1 
1 Department of Ophthalmology, Faculty of Medicine, Sohag University, Sohag, Egypt 
2 Department of Ophthalmology, Qena General Hospital, Qena, Egypt 
ABSTRACT 
Background: We evaluated and compared outcomes of laser-assisted in situ keratomileusis (LASIK) versus optical spectacle 
correction for the treatment of anisometropia in adult patients. 
Methods: This prospective, randomized controlled clinical trial included 50 eyes of 50 patients. We randomly allocated 
participants to Group A (25 eyes with anisometropia assigned to LASIK treatment) and Group B (25 eyes with 
anisometropia assigned to optical spectacle correction). All patients underwent preoperative and postoperative visual 
acuity, subjective and cycloplegic refraction, fundus, slit-lamp, and corneal topography examinations. 
Results: In Group A, at 1-month postoperatively, there were statistically significant differences in uncorrected distance 
visual acuity, corrected distance visual acuity, refractive sphere, cylinder, and spherical equivalent (SE) as compared to 
baseline. At 3-months postoperatively in Group A, SE showed good stability within ± 0.50 diopter (D) in 22 eyes (88%) and 
within ± 0.75 D in 23 eyes (92%), while two eyes had an SE beyond 1.00 D emmetropia. Five eyes had amblyopia with 
minimal improvement in two eyes in Group A after LASIK, and no improvement in three eyes treated with spectacles in 
Group B. Two amblyopic eyes had developed ocular deviations by the end of the study that referred to the strabismus 
unit. 
Conclusions: Our outcomes revealed that LASIK was more effective and advantageous than spectacles in the treatment of 
different types of anisometropia in adults. However, future randomized trials should focus on optical versus surgical 
treatment of anisometropia and anisometropic amblyopia in both pediatric and adult patients, to verify these conclusions 
before generalizing this treatment modality. 
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INTRODUCTION 
Anisometropia is defined as a marked refractive power 
difference of more than two diopters (D) between the 
bilateral eyes of the same individual. It comprises simple, 
compound, and mixed anisometropia [1-3]. The etiology 
of unilateral amblyopia is classified into three major 
categories of visual abnormalities. The first category is 
anisometropia, the second category is strabismus. The 
third category is visual deprivation in one eye only due to 
opacities in the media, such as unilateral congenital 
cataract, corneal haziness or opacification, corneal 
ectasia, or advanced ptosis [4]. On the other hand, the 
etiology of bilateral amblyopia is classified into two major 
categories of visual abnormalities. The first category is 
marked ametropia, such as bilateral high hypermetropic 




Med Hypothesis Discov Innov Optom. 2020; 1(2)  
58 SURGICAL VERSUS OPTICAL TREATMENT FOR ANISOMETROPIA IN ADULTS 
category is visual deprivation in one eye only due to 
opacities in the media, such as bilateral congenital or 
developmental cataracts, bilateral corneal scarring, and 
bilateral advanced ptosis [5].    
Amblyopia is a disorder in which the eye and brain cannot 
work together well, resulting in decreased vision in an eye 
that may typically appear normal. This may affect 1–5% of 
the population, while anisometropic amblyopia is the 
second most common cause [6, 7]. Without treatment, 
amblyopia typically persists into adulthood. Treatment 
prognosis in adults is not promising [8].  
Anisometropic amblyopia may be treated optically with 
spectacles or surgically with laser-assisted in situ 
keratomileusis (LASIK). LASIK is the most popular 
refractive surgery for the correction of refractive errors 
and is one of the most common surgeries performed 
worldwide [9]. The efficacy of treatment is affected by 
numerous prognostic factors, including uncorrected 
distance visual acuity (UDVA) and corrected distance 
visual acuity (CDVA) prior to treatment, level of 
anisometropia severity, patient age, and cooperation [10, 
11].  
In this prospective, randomized, controlled clinical trial, 
our primary objective was to document the efficacy of 
LASIK in treating anisometropia, while our secondary 
objective was to compare LASIK versus spectacles for 
treating anisometropia. 
METHODS 
This study was a prospective, comparative, randomized, 
controlled clinical trial approved by the Ethical Committee 
of the Faculty of Medicine, Sohag University, Egypt. It was 
registered at the Pan-African Clinical Trial Registry (PACTR) 
with registry number (PACTR201906462665442). This 
study was performed from July 2019 to March 2020 and 
was designed as a double-blind, randomized clinical trial 
in which both the treatment assignments were masked for 
both recruited participants and investigators (treatment 
team and evaluators).  
The subject inclusion criteria were as follows: age > 18 
years, clear cornea, and refractive difference of ≥ 4 D 
between bilateral eyes. The exclusion criteria consisted of 
unstable refraction; a difference between the manifest 
refraction and cycloplegic refractions > 1 D; hazy, thin or 
ectatic corneas; corneal or lens opacities; diabetic 
patients; pregnancy; and lactation. Participants with 
anisometropic amblyopia were also included in the study.  
The nature of the disease (anisometropia or 
anisometropic amblyopia) was explained in detail to the 
patient or their guardians while receiving consent prior to 
surgery. We recruited 62 patients; however, 12 patients 
with thin, opaque, or ectatic corneas were excluded. 
Finally, this study included 50 patients who were 
randomized to two groups. Group A (experimental group) 
included 25 eyes of 25 patients with anisometropia 
assigned for LASIK surgery at the Eye LASIK Center, Sohag, 
Egypt, using the 200-Hz Allegretto excimer laser (Alcon 
Laboratories, Inc., Irvine, CA). Group B (control group) 
included 25 eyes of 25 patients with anisometropia 
treated with spectacles. 
All patients underwent a complete ophthalmological 
examination, including the following: Both UDVA and 
CDVA were assessed with a decimal system (Auto Chart 
Projector PACP-7000/PACP-7000L, Potec Co., Ltd. Dong-
gu, Korea). Manifest refraction was evaluated using a 
Topcon RM-800 autorefractometer (Topcon Medical 
System, Japan), and subjective refraction was evaluated 
using a trial lens set (TLS-232, Shanghai Link Instruments 
Co. China). Slit-lamp examination (SL-3 slit-lamp, 
ChongQing SunKingdom Medical Instrument Co. Ltd, 
China), fundus examination, and corneal topography 
(TMS-4; Tomey, Erlangen, Germany) were also evaluated. 
Cycloplegic refraction was evaluated by instillation of one 
drop of combined 0.2% cyclopentolate and 0.1% 
phenylephrine (Cyclophrine; Kahira Pharmaceuticals & 
Chemical Industries Company, Cairo, Egypt) into the eyes 
every 10 min for 30 min, after which cycloplegic refraction 
was measured using a Topcon RM-800 auto-
refractometer.  
All patients were subjected to subjective refraction 
measurement using a trial for spectacles tested with the 
trial lens set. Cyclophrine eye drops were instilled every 
10 min for 30 min before cycloplegic refraction was 
measured. Spectacle prescription accuracy was checked 
using a lensmeter (Topcon, LM-8, 75-1 Hasunuma-Cho, 
Itabashi-Ku, Tokyo, Japan). 
For recruited subjects in Group A, Benox® (benoxinate 
hydrochloride 4 mg, Egyptian International 
Pharmaceutical Industries Company, 10th Of Ramadan 
City, Egypt) was instilled 10 min before surgery. The 
patient was reassured and requested to remain calm. The 
eyelids, lashes, forehead, and part of the face were 
sterilized with betadine, after which a disposable plastic 
eyelid drape was used to cover the eye. We then inserted 
an eye speculum, followed by marking the corneal 
paracentral area with a pen marker. A suction ring was 
then applied to the sclera surrounding the limbus. A 
microkeratome (Moria Inc., Amico, Doylestown, PA) was 
then used to create a uniformly thick corneal flap. A 
spatula was used to reflect the corneal flap, and a 
microsponge was used to dry the stromal bed. LASIK was 
performed using a 200-Hz Allegretto excimer laser (Alcon 
Laboratories, Inc., Irvine, CA). The patient was instructed 
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to fixate on the flashing light that emerged from the 
excimer laser during the stromal ablation. Finally, the flap 
was repositioned by washing the interface between the 
flap and the stromal bed. Topical dexamethasone 0.1% + 
tobramycin 0.3% eye drops (Tobradex; Alcon, Fort Worth, 
TX) were then instilled into the eye, and the speculum was 
gently removed from the eye.  In Group B, the patients’ 
spectacles were carefully adjusted to achieve the best 
CDVA. Of note, amblyopic therapy was not performed, 
because all patients were 18 years old and older. 
In Group A, a drop of topical gatifloxacin 0.3% (Tymer 
Jamjoom Pharmaceuticals, Jeddah, Saudi Arabia), as 
antibiotic eye drops, was instilled every hour on the first 
day and then five times per day in the first week. In 
addition, a drop of prednisolone acetate ophthalmic 
suspension 1.0% (Optipred, Jamjoom Pharma, Saudi 
Arabia) was instilled every hour on the first day, then five 
times per day in the first week, four times per day in the 
second week, three times per day in the third week, and 
two times per day in the fourth week of surgery. 
Furthermore, a drop of lubricant eye drops containing 
polyethylene glycol 0.4% and propylene glycol 0.3% 
(Systane ® Ultra Lubricant Eye Drops, Alcon Laboratories, 
Inc.) was instilled every hour on the first day of surgery, 
then five times per day in the first month and three times 
per day for another two months after LASIK. All patients 
were examined after LASIK for 10‒15 min. Follow-up visits 
were scheduled at the first postoperative day, first 
postoperative week, and first and third postoperative 
months. All patients were examined using a slit lamp, and 
visual acuity was measured. All study patients completed 
their 3-month follow-up; there were no drop-out cases. 
Figure 1 shows a flowchart of the distribution of the 
participants included in our study. 
Wilcoxon’s test was used to analyze non-normally 
distributed data. Furthermore, we used a paired-samples 
t-test to compare normally distributed data. Data were 
analyzed using IBM SPSS Statistics for Windows version 22 
software (IBM Corp., Armonk, NY). Postoperative 
outcomes were considered significant at the 5% level. 
RESULTS 
Our study included 50 eyes of 50 patients (23 men and 27 
women). Group A included 13 men and 12 women, while 
Group B included 10 men and 15 women. The mean ± 
standard deviation (SD) of age was 23.86 ± 4.29 years in 
the LASIK group (Group A) and 25.88 ± 6.73 years in the 
spectacles group (Group B). 
Of the 25 included cases in Group A, 17 were myopic eyes, 
six were hyperopic eyes, and two were astigmatic eyes. Of 
the 25 included cases in Group B, 14 were myopic eyes, 
eight were hyperopic, and three were astigmatic (Table 1). 
Of the five eyes with anisometropic amblyopia, two eyes 
in Group A , while three eyes in Group B. Figures 2 and 3 
show the mean differences between the baseline and final 
spherical, cylindrical, and SE values of refraction in Groups 
A and B. Table 1 summarizes the baseline distribution of 
the refractive errors in Groups A and B.  
In Group A, the mean ± SD sphere of myopic eyes was -4.0 
± 1.0 D, the mean ± SD sphere of hyperopic eyes was +3.9 
± 1.2 D, and the mean ± SD refraction values of astigmatic 
eyes was -3.0 ± 0.0 D. In Group B, the mean ± SD sphere of 
myopic eyes was -5.3 ± 1.6 D, the mean ± SD sphere of 
hyperopic eyes was +4.2 ± 1.9 D, and the mean ± SD 
refraction values of astigmatic eyes was -4.3 ± 0.4 D. The 
baseline values of myopia and astigmatism in Group A 
were significantly lower than those in Group B (P = 0.001 
and P = 0.0001, respectively); however, although the 
baseline values of hyperopia were lower than those in 
Group B, there was no significant difference between the 
two groups (P = 0.50) (Table 1).  
Tables 2 and 3 summarize the baseline and final data of 
sound versus anisometropic eyes in in both groups, 
respectively. Overall, the final UCVA improved by two or 
more lines in all participants in both groups. We detected 
the same CDVA as baseline or even better than baseline in 
92% of the patients at the end of the trial. The mean ± SD 
of baseline UDVA and CDVA of the sound eye in Group A, 
was 0.8 ± 0.13, and 0.9 ± 0.06, respectively. The mean ± 
SD of baseline spherical component of refraction, 
cylindrical component of refraction, and spherical 
equivalent (SE) in the sound eye for Group A, was -0.33 ± 
0.7 D, -0.59 ± 0.39 D, and -0.64 ± 0.7 D (Table 2).   The 
mean ± SD baseline UDVA and CDVA of anisometropic eye 
in patients in Group A were 0.24 ± 0.16, and 0.82 ± 0.13, 
respectively. The mean ± SD baseline spherical component 
of refraction, cylindrical component of refraction, and SE 
were -1.6 ± 3.5 D, -1.28 ± 0.9 D, and -2.19 ± 3.3 D, 
respectively (Table 2). The mean ± SD baseline UDVA and 
CDVA of the sound eye for Group B were 0.76 ± 0.13 and 
0.98 ± 0.04, respectively. The mean ± SD baseline spherical 
component of refraction, cylindrical component of 
refraction, and SE in the sound eyes of Group B were -
0.34± 0.8 D, -0.65 ± 0.4 D, and -0.76 ± 0.8 D (Table 2). The 
mean ± SD baseline UDVA and CDVA of the anisometropic 
eye in patients in Group B were 0.18 ± 0.16 and 0.6 ± 0.2, 
respectively. The mean ± SD of the baseline spherical 
component of refraction, cylindrical component of 
refraction, and SE were -1.7 ± 3.5 D, -1.4 ± 1.4 D, and -2.9 
± 4.1 D, respectively. Except for baseline CDVA, which was 
significantly different (P = 0.0001), we did not detect any 
significant differences in other variables between the two 
study groups (Table 2).  
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Figure 1. Flowchart of the distribution of participants in the refractive surgical versus optical treatment for anisometropia in adults clinical trial. 
Abbreviations: n, number; UDVA, uncorrected distance visual acuity; CDVA, corrected distance visual acuity; SE, spherical equivalent; LASIK, laser–
assisted in situ keratomileusis 
 
Assessed for eligibility (N = 62) 
Excluded (N = 12) 
 
   Due to thin, opaque, or ectatic corneas (N = 12) 
 
Analysed  (N =  25) 
 Excluded from analysis (N = 0) 
Lost to follow-up (N = 0) 
Discontinued intervention (N = 0) 
Allocated to LASIK surgery (N = 25) 
 Received LASIK surgery (N =  25) 
 Did not receive LASIK surgery (N = 0) 
Lost to follow-up (N = 0) 
Discontinued intervention (N = 0) 
Allocated to spectacles prescription (N = 25) 
 Received spectacles (N =  25) 
 Did not receive spectacles (N =  0) 
Analysed  (N = 25) 





Randomized (N = 50)  
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Figure 2. Mean differences between the baseline sphere, cylinder, and the spherical equivalent (SE) values of Group A (LASIK) versus Group B (Spectacles). 
Abbreviations: LASIK, laser–assisted in situ keratomileusis; D, diopter; SE, spherical equivalent; Sphere, spherical component of refraction; Cylinder, 





Figure 3. The mean differences between the final sphere, cylinder, and the SE of Group A versus Group B. Abbreviations: LASIK, laser–assisted in situ 
keratomileusis; D, diopter; SE, spherical equivalent; Sphere, spherical component of refraction; Cylinder, cylinderical component of refraction 
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Table 1. Baseline distribution of the refractive errors in Group A (LASIK) versus Group B (Spectacles). 
Variable Group A 
mean ± SD 
Group B 
mean ± SD 
95% Confidence Interval  

































-3.0 ± 0.0 
 
3 







Abbreviations: LASIK, laser–assisted in situ keratomileusis; %, percentage; n, number; D, dioptre; SD, standard deviation; Sphere, spherical component 
of refraction; Cylinder, cylinderical component of refraction. P < 0.05 is shown in bold 
  
Table 2. Baseline data of sound versus anisometropic eyes in Groups A (LASIK) and B (Spectacles). 
Variable Sound eyes of 
Group A 
mean ± SD 
Sound eyes of 
Group B 
mean ± SD 
P-value 
 
Anisometropic eyes of 
Group A 
mean ± SD 
Anisometropic eyes of 
Group B 




0.8 ± 0.13 0.76 ± 0.13 0.3 0.24 ± 0.16 0.18 ± 0.16 0.2 
CDVA 
(decimal) 
0.9 ± 0.06 0.98± 0.04 0.0001 0.82 ± 0.13 0.6 ± 0.2 0.0001 
Sphere (D) -0.33 ± 07 -0.34 ± 0.8 0.9 -1.6 ± 35 -1.7 ± 3.5 0.9 
Cylinder (D) -0.59 ± 0.39 -0.65 ± 0.4 0.6 -1.28 ± 0.9 -1.4 ± 1.4 0.7 
SE (D) -0.64 ± 0.7 -0.76 ± 0.8 0.6 -2.19 ± 3.3 -2.9 ± 4.1 0.5 
Abbreviations: LASIK, laser–assisted in situ keratomileusis; SD, standard deviation; D, dioptre; UDVA, uncorrected distance visual acuity; CDVA, corrected 
distance visual acuity; SE, spherical equivalent; Sphere, spherical component of refraction; Cylinder, cylinderical component of refraction. P < 0.05 is 
shown in bold 
 
 
Table 3.  Final outcome of sound versus anisometropic eyes in Groups A (LASIK) and B (Spectacles). 
Variable Sound eyes of 
Group A 
mean ± SD 
Sound eyes of 
Group B 
Mean ± SD 
P-value 
 
Anisometropic eyes of 
Group A 
mean ± SD 
Anisometropic eyes of 
Group B 
mean ± SD 
P-value 
UDVA (decimal) 0.9 ± 0.08 0.76 ± 0.13 0.0001 0.82 ± 0.13 0.18 ± 0.16 0.0001 
CDVA (decimal) 0.96 ± 0.06 0.98 ± 0.04 0.2 0.87 ± 0.1 0.6 ± 0.2 0.0001 
Sphere (D) -0.17 ± 0.4 -0.34 ± 0.8 0.3 -0.2 ± 0.3 -1.7 ± 3.5 0.0001 
Cylinder (D) -0.4 ± 0.3 -0.65 ± 0.4 0.02 -0.25 ± 0.3 -1.4 ± 1.4 0.0002 
SE (D) -0.42 ± 0.4 -0.76 ± 0.8 0.06 -0.35 ± 0.4 -2.9 ± 4.1 0.003 
Abbreviations: LASIK, laser–assisted in situ keratomileusis; SD, standard deviation; D, dioptre; UDVA, uncorrected distance visual acuity; CDVA, corrected 
distance visual acuity; SE, spherical equivalent; Sphere, spherical component of refraction; Cylinder, cylinderical component of refraction. P < 0.05 is 
shown in bold 
 
Table 4. Baseline and final visual acuity and refractive outcomes in Group A (LASIK). 
Variable Baseline data 
mean ± SD 
Final data 
mean ± SD 
P-value 
UDVA (decimal) 0.24 ± 0.16 0.82 ± 0.13 <0.0001 
CDVA (decimal) 0.82 ± 0.13 0.87 ± 0.1 0.001 
Sphere (D) -1.6± 3.5 -0.2 ± 0.3 0.02 
Cylinder (D) -1.28 ± 0.9 -0.25 ± 0.3 <0.0001 
SE (D) -2.19 ± 3.3 -0.35 ± 0.4 <0.0001 
Abbreviations: LASIK, laser–assisted in situ keratomileusis; SD, standard deviation; D, dioptre; UDVA, uncorrected distance visual acuity; CDVA, corrected 
distance visual acuity; SE, spherical equivalent; Sphere, spherical component of refraction; Cylinder, cylinderical component of refraction. P < 0.05 is 
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mean ± SD 
Group B 
mean ± SD 
95% Confidence Interval  
of mean differences 
P-value 
UDVA (decimal) 0.24 ± 0.16 0.18 ± 0.16 0.06 (-0.03‒0.15) 0.2 
CDVA (decimal) 0.82 ± 0.13 0.6 ± 0.2 0.2 (0.12‒0.32) 0.0001 
Sphere (D) -1.6 ± 3.5 -1.7 ± 3.5 0.1 (-2.2‒2.4) 0.9 
Cylinder (D) -1.28 ± 0.9 -1.4 ± 1.4 0.12 (-0.55‒0.79) 0.7 
SE (D) -2.19 ± 3.3 -2.9 ± 4.1 0.7 (-1.4‒2.8) 0.5 
Abbreviations: LASIK, laser–assisted in situ keratomileusis; SD, standard deviation; D, dioptre; UDVA, uncorrected distance visual acuity; CDVA, corrected 
distance visual acuity; SE, spherical equivalent; Sphere, spherical component of refraction; Cylinder, cylinderical component of refraction. P < 0.05 in bold 
 




mean ± SD 
Group B 
mean ± SD 
95% Confidence Interval  
of mean differences 
P-value 
UDVA (decimal) 0.82 ± 0.13 0.18 ± 0.16 0.64 (0.56‒0.72) 0.0001 
CDVA (decimal) 0.87 ± 0.1 0.6 ± 0.2 0.27 (0.18‒0.36) 0.0001 
Sphere (D) -0.2 ± 0.3 -1.7 ± 3.5 1.5 (-0.3‒3.3) 0.0001 
Cylinder (D) -0.25 ± 0.3 -1.4 ± 1.4 1.15 (0.6‒1.7) 0.0002 
SE (D) -0.35 ± 0.4 -2.9 ± 4.1 2.6 (0.9‒4.2) 0.003 
Abbreviations: LASIK, laser–assisted in situ keratomileusis; SD, standard deviation; D, dioptre; UDVA, uncorrected distance visual acuity; CDVA, corrected 
distance visual acuity; SE, spherical equivalent; Sphere, spherical component of refraction; Cylinder, cylinderical component of refraction. P < 0.05 is 
shown in bold 
 
Table 7. Outcome of the five eye with anisometropic amblyopia in both study groups. 
n Group Patient UDVA CDVA Sphere (D) Cylinder (D) SE (D) Strabismus Note 
B F B F B F B F B F 
1 A OD of 27-year-old 
female patient 






OS of 20-year-old 
female patient 









OD of 18-year-old 
male patient 







OD of 23-year-old 
male patient 






OS of 31-year-old 
female patient 
0.05 NI 0.05 NI +5.50 NI -1.00 NI +5.00 NI No  
- 
Abbreviations: n, eye number; Group A, LASIK (laser–assisted in situ keratomileusis) treatment group; Group B, spectacle corrected Group; OD, right eye; 
OS, left eye; B: baseline data; F, Final data; D, diopter; UDVA, uncorrected distance visual acuity in decimal; CDVA, corrected distance visual acuity in 
decimal; Sphere, spherical component of refraction; Cylinder, cylinderical component of refraction; SE, spherical equivalent; XT, exotropia; ET, esotropia; 
NI, not improved
 
The mean ± SD of the final UDVA and CDVA of the sound 
eyes in Group A were 0.9 ± 0.08 and 0.96 ± 0.06, 
respectively. The mean ± SD final spherical component of 
refraction, cylindrical component of refraction, and SE 
were -0.17 ± 0.4, -0.4 ± 0.3 D and -0.42 ± 0.4, respectively 
(Table 3). The mean ± SD final UDVA and CDVA of the 
anisometropic eyes in patients in Group Awere 0.82 ± 0.13 
and 0.87 ± 0.1, respectively. The mean ± SD final spherical 
component of refraction, cylindrical component of 
refraction, and SE were -0.2 ± 0.3 D, -0.25 ± 0.3 D, and -
0.35 ± 0.4 D, respectively (Tables 3, 4, and 6). The mean ± 
SD final UDVA and CDVA of the sound eyes in Group B 
were 0.76 ± 0.13, and 0.98 ± 0.04, respectively. The mean 
± SD of final spherical component of refraction, cylindrical 
component of refraction, and SE was -0.34 ± 0.8, -0.65± 
0.4 D and -0.76 ± 0.8, respectively (Table 3). The mean ± 
SD of the final UDVA and CDVA of the anisometropic eyes 
in Group B was 0.18 ± 0.16, and 0.6 ± 0.2, respectively. The 
mean ± SD final spherical component of refraction, 
cylindrical component of refraction, and SE were -1.7 ± 3.5 
D, -1.4 ± 1.4 D, and -2.9 ± 4.1 D, respectively (Tables 3, and 
6). In sound eyes, UDVA, and the cylindrical component of 
refraction improved significantly in Group A as compared 
to the Group B (P = 0.0001, and 0.02, respectively). 
However, in anisometropic eyes, all variables, including 
UDVA, CDVA, spherical component of refraction, 
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cylindrical component of refraction, and SE improved 
significantly in Group A as compared with Group B (P = 
0.0001, 0.0001, 0.0001, 0.0002, and 0.003, respectively) 
(Table 3). Compared with baseline values, all variables 
including UDVA, CDVA, spherical component of refraction, 
cylindrical component of refraction, and SE had improved 
significantly in Group Aby the end of the trial (P < 0.0001, 
0.001, 0.02, < 0.0001, and < 0.0001, respectively) (Table4). 
In terms of the accuracy of LASIK eyes, at the end of the 
follow-up, the final SE was within ± 0.50 D in 22 eyes (88%) 
and within ± 0.75D in 23 eyes (92%). Two eyes had an SE 
beyond 1.00 D of emmetropia. In terms of UDVA by 3 
months after LASIK, 8% (two eyes) obtained CDVA 1.0, 
20% (five eyes) obtained CDVA 0.9, 28% (seven eyes) 
obtained CDVA of 0.8, 28% (seven eyes) obtained a CDVA 
of 0.7, and 16% (four eyes) had a CDVA ≤ 0.6. In this study, 
compared with their preoperative CDVA values, five eyes 
(20%) experienced a two-line visual acuity improvement, 
14 eyes (56%) experienced a one-line improvement, three 
eyes had no improvement (or worse UCVA) in their 
postoperative CDVA, while two eyes were worse by one 
line. In our study, 19 eyes (76%) had increased CDVA by 
one to two lines, three eyes (16%) had the same CDVA as 
preoperatively, and two eyes (8%) had lost one line. 
In Group B, the mean ± SD baseline UDVA and CDVA were 
0.18 ± 0.16 and 0.6 ± 0.2, respectively. The mean ± SD 
baseline spherical component of refraction, cylindrical 
component of refraction, and SE were -1.7 ± 3.5 D, -1.4 ± 
1.4 D, and -2.9 ± 4.1 D (Table 5). Moreover, 8% (two eyes) 
obtained CDVA 1.0, 12% (three eyes) obtained CDVA 0.9, 
16% (four eyes) obtained CDVA 0.8, 28% (seven eyes) 
obtained CDVA 0.7, and 36% (nine eyes) had a CDVA ≤ 0.6. 
In our study, there were five eyes with anisometropic 
amblyopia: two in the LASIK group, and three in the 
spectacle group. The two amblyopic eyes in the LASIK 
group showed a slight improvement in visual acuity (Table 
7). Despite our documentation of new strabismus in two 
eyes at the end of the study, we acknowledge that 
strabismus was not one of our inclusion criteria. 
Eventually, we referred both patients to the Strabismus 
Unit for further assessment and management (Table 7).  
During the study, seven eyes of the LASIK group 
experienced complications. One case had an 
intraoperative complication in the form of minimal limbal 
bleeding that was treated by gentle pressure on the 
oozing vessels and irrigation of the interface. LASIK 
ablation continued as usual and the patient was examined 
15 minutes after LASIK and the next day by slit-lamp for 
any blood or debris, and was found to have none. Two 
eyes had dry eye and were prescribed artificial tears with 
close follow-up for 3 months. Postoperative haze was 
documented in two eyes (8%) following LASIK and 
revealed a good response to medical treatment. Finally, 
two eyes (8%) exhibited slight postoperative under-
correction. 
DISCUSSION    
In anisometropia, the main aim of treatment is to correct 
the refractive errors in the anisometropic eye to mimic the 
refractive status of the sound eye. In the current study, in 
all study eyes of the LASIK group, the final UDVA exhibited 
good improvement, by at least two lines. Furthermore, 
the final UDVA in 92% of LASIK eyes was the same as the 
baseline or better than the baseline CDVA. In sound eyes, 
UDVA, and cylindrical component of refraction SE were 
significantly improved in the LASIK group as compared 
with the spectacle group. In the anisometropic eyes, all 
variables including UDVA, CDVA, spherical component of 
refraction, cylindrical component of refraction, and SE 
improved significantly in the LASIK group compared with 
the spectacle group. In our study, compared with baseline 
values, all variables, including UDVA, CDVA, spherical 
component of refraction, cylindrical component of 
refraction, and SE, had improved significantly in the LASIK 
group by the end of the trial.  
Dedhia and Behl [12] evaluated the efficacy and benefits 
of LASIK in the treatment of anisometropic amblyopia. The 
study included 21 anisometropic amblyopic eyes in adult 
and pediatric patients, with a mean age of 27.71 years, 
who underwent LASIK treatment and were followed-up 
for 3 months. On the other hand, our study included only 
five anisometropic amblyopic eyes, in adult patients only, 
with a mean age of 23.86 years, who underwent LASIK 
treatment and were followed-up for 3 months. The 
preoperative mean ± SD of manifest SE refraction in their 
study was -2.19 ± 3.3 D, and the postoperative UCVA 
improved by at least two visual acuity lines in all cases. 
This was similar to or even better than the baseline CDVA 
in 95.2% of eyes [12].  In our study, the mean ± SD baseline 
UDVA and CDVA were 0.24 ± 0.16 and 0.82 ± 0.13, 
respectively. The mean ± SD baseline spherical component 
of refraction, cylindrical component of refraction, and SE 
were -1.6 ± 3.5 D, -1.28 ± 0.9 D, and -2.19 ± 3.3 D. Finally, 
the mean ± SD UDVA and CDVA were 0.82 ± 0.13 and 0.87 
± 0.1, representing a significant improvement compared 
to baseline. The mean ± SD final spherical component of 
refraction, cylindrical component of refraction, and SE 
were -0.2 ± 0.3 D, -0.25 ± 0.3 D, and -0.35 ± 0.4D, which 
also represented a significant improvement compared to 
baseline. 
Sakatani et al. [13] evaluated improvement in CDVA using 
spectacles after LASIK in adult patients with amblyopia. 
UDVA in seven eyes (33.3%) improved by at least one line 
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postoperatively, as compared to the preoperative values, 
and nine eyes (42.8%) improved by at least one line in 
postoperative CDVA compared to the preoperative 
values. Furthermore, they reported stability of 
postoperative CDVA in ˃ 50% of eyes with unchanged 
preoperative best spectacle-corrected visual acuity 
values. They also recorded deterioration of postoperative 
CDVA in one eye, which lost two visual acuity lines 
postoperatively [13]. In contrast, our study included only 
five eyes with anisometropic amblyopia, and only two 
eyes were treated with LASIK, who had only one visual 
acuity line of postoperative UDVA improvement. 
Ghanem et al.  [14] reported the outcomes of the 
treatment of 18 pediatric eyes with LASIK. Their study eyes 
were myopic, anisometropic, and amblyopic, which failed 
to respond to amblyopia therapy for 6 months before 
LASIK treatment. Furthermore, after LASIK treatment, the 
study eyes were subjected to another round of amblyopia 
therapy, particularly occlusion therapy, on a 6-hourly basis 
for 12 weeks, followed by maintenance occlusion therapy 
on a 4-hourly basis for a few more months. Finally, they 
concluded that LASIK treatment could be considered as an 
ideal treatment in pediatric eyes with intolerance to 
contact lenses or spectacle wear. They also stated that 
LASIK is effective in the treatment of amblyopic eyes due 
to myopic anisometropia, as it also improved both 
postoperative CDVA and binocular vision [14]. On the 
other hand, our study included only adult patients with a 
limited number (five eyes) of anisometropic amblyopia 
due to myopia, hyperopia, or astigmatism. We did not 
recommend amblyopia therapy in our patients, as they 
were all adults.  
In another study, Rafai et al. [15] analyzed the 
effectiveness of LASIK in treating refractive errors to 
improve postoperative CDVA in anisometropic amblyopic 
eyes. Their study included 20 eyes with amblyopia 
originating from related anisometropia. All of their study 
eyes underwent LASIK treatment. The mean ± SD age of 
the patients was 28.00 ± 7.91 years, ranging from 16 to 42 
years. Sixteen eyes (80%) improved by one to five lines of 
CDVA, whereas the remaining four eyes (20%) had the 
same CDVA as preoperatively. Finally, none of their study 
eyes deteriorated or exhibited loss of any visual lines of 
CDVA [15]; however, in our study, 19 eyes (76%) improved 
by one to two lines of CDVA, three eyes (16%) had the 
same CDVA as preoperatively, and two eyes (8%) lost one 
line. In our study, compared with baseline values, all 
variables, including UDVA, CDVA, spherical component of 
refraction, cylindrical component of refraction, and SE, 
had improved significantly in the LASIK group by the end 
of the trial. However, as we had a limited number of 
patients with anisometropic amblyopia, an accurate 
comparison of our results with the outcomes of Rafai et al. 
is not possible 
The strengths of our study originate from two main 
factors. First, our study was a randomized controlled trial 
that included a relatively larger sample size (50 eyes) than 
previous relevant studies. The second factor was the 
inclusion of a limited number of anisometropic amblyopic 
eyes in each group, to document the impact of LASIK 
versus spectacles in treating anisometropic amblyopia in 
adults. However, our study was limited in that the follow-
up period was short (3 months). 
Considering the significant improvement in all variables in 
the LASIK group, we suggest that LASIK might be a better 
option for treating anisometropia in adults in our area, as 
many patients are farmers and construction workers who 
seek non-optical options to treat their anisometropia to 
suit their work conditions. However, anisometropic 
amblyopia remained an obstacle and showed almost no 
significant improvement in response to either optical or 
surgical treatment. Finally, we recommend further 
randomized trials with a focus on optical versus surgical 
treatment of anisometropia and anisometropic amblyopia 
in both pediatric and adult patients to confirm the 
conclusions of this study, before generalizing this 
treatment modality. We also recommend that future 
studies should include a patient satisfaction scale and the 
outcomes of corneal tomography and topography. 
CONCLUSIONS 
In conclusion, our results showed that LASIK was effective 
and sometimes more advantageous than spectacles in the 
treatment of different types of anisometropia in adults. 
However, future randomized trials with a focus on optical 
versus surgical treatment of anisometropia and 
anisometropic amblyopia in both pediatric and adult 
patients are needed to verify our conclusions, to confirm 
the generalizability of this treatment modality. 
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